Abstract:Cancer progression is an intricate biological process profiled by not only unscheduled proliferation, but also altered metabolism mechanisms. In this article, we introduced a novel tumor suppressor gene (TSG), Zinc Finger DHHC-Type Containing 1 (ZDHHC1, also known as ZNF377), frequently silenced due to epigenetic modification among various cancers, which exerts significant anti-tumor effects through metabolic regulation.Methods: Quantitative reversed-transcription PCR (qRT-PCR), reverse transcription PCR (RT-PCR) and Western blot were employed to demonstrate transcriptional and protein levels of targeted regulators. Methylation of ZDHHC1 promoter was detected by bisulfite genomic sequencing (BGS) and methylation specific PCR (MSP). Proteomics were analyzed by isobaric tags for relative and absolute quantitation (iTRAQ) and gas chromatography-mass spectrometry (GC-MS) were utilized for metabolomics analysis. Cellular functions were examined via corresponding approaches. Nude mice were used for xenograft tumor models. Indirect immunofluorescence staining was utilized to obtain precise location and expression of target proteins. Oxidative and ER stress indicators were detected using specific kits.Results: We found that ZDHHC1 expression was frequently silenced in multiple tumor cells and specimens due to methylation. Restoration of ZDHHC1 expression can curb cancer cell progression via stimulating apoptosis and cell cycle arrest, repressing metastasis, and reversing EMT transition and cell stemness. ZDHHC1's salient anti-tumor abilities were recognized in vivo as well. Metabolomic and proteomic analyses predicted inhibitory role of ZDHHC1 in glucose metabolism pathways in a CYGB-dependent manner, and in pentose phosphate pathway (PPP), which was validated by examining altered key factors. Moreover, we unraveled that ZDHHC1 dedicates to the increment of oxidative stress and endoplasmic reticulum (ER) stress to promote pyroptosis for anticancer purposes.Conclusion: Our study for the first time indicates ZDHHC1 is a potential tumor-suppressor frequently silenced due to promoter methylation, capable of negatively regulating metabolisms of tumor cells while stimulating oxidative stress and ER stress to expedite cell death through induction of pyroptosis and apoptosis, which can be exploited for development of new cancer prevention and therapies.

A Novel 19q13 Nucleolar Zinc Finger Protein Suppresses Tumor Cell Growth through Inhibiting Ribosome Biogenesis and Inducing Apoptosis but Is Frequently Silenced in Multiple Carcinomas

Supplementary Figure 3 from A Novel 19q13 Nucleolar Zinc Finger Protein Suppresses Tumor Cell Growth Through Inhibiting Ribosome Biogenesis and Inducing Apoptosis but is Frequently Silenced in Multiple Carcinomas

Zinc-finger Protein 545 is a Novel Tumour Suppressor That Acts by Inhibiting Ribosomal RNA Transcription in Gastric Cancer

ZNF545 loss promotes ribosome biogenesis and protein translation to initiate colorectal tumorigenesis in mice

Supplementary Table 2 from A Novel 19q13 Nucleolar Zinc Finger Protein Suppresses Tumor Cell Growth Through Inhibiting Ribosome Biogenesis and Inducing Apoptosis but is Frequently Silenced in Multiple Carcinomas

Abstract 830: ZFP14, a p53 target, suppresses tumor formation by regulating HOXA gene cluster expression

Zinc-finger Protein 545 Inhibits Cell Proliferation As a Tumor Suppressor Through Inducing Apoptosis and is Disrupted by Promoter Methylation in Breast Cancer.

Zinc-finger Protein 545 is Inactivated Due to Promoter Methylation and Functions As a Tumor Suppressor Through the Wnt/β-catenin, PI3K/AKT and MAPK/ERK Signaling Pathways in Colorectal Cancer.

Epigenetic Identification, of Znf545 As A Functional Tumor Suppressor in Multiple Myeloma Via Activation of P53 Signaling Pathway

ZNF545 Suppresses Human Hepatocellular Carcinoma Growth by Inhibiting NF-kB Signaling.

The Epigenetic Modifier PRDM5 Functions As a Tumor Suppressor Through Modulating WNT/β-catenin Signaling and is Frequently Silenced in Multiple Tumors.

The Novel 19q13 KRAB Zinc-Finger Tumour Suppressor ZNF382 is Frequently Methylated in Oesophageal Squamous Cell Carcinoma and Antagonises Wnt/β-catenin Signalling

Zic1 Is Downregulated Through Promoter Hypermethylation, And Functions As A Tumor Suppressor Gene In Colorectal Cancer

Downregulation of ZNF365 by Methylation Predicts Poor Prognosis in Patients with Colorectal Cancer by Decreasing Phospho-P53 (ser15) Expression

ZNF382:a Transcription Inhibitor Down-Regulated in Multiple Tumors Due to Promoter Methylation.

The Novel Zinc Finger Protein 587B Gene, ZNF587B, Regulates Cell Proliferation and Metastasis in Ovarian Cancer Cells in Vivo and in Vitro.

Pharmacologic demethylation identifies UCHL1 as a tumor suppressor gene frequently silenced in nasopharyngeal and multiple other carcinomas

ZNF671 Silencing Affects Signaling Pathways in Head and Neck Cancer via Activation of Oncogenic Non-Coding RNAs

DNA methylation downregulated ZDHHC1 suppresses tumor growth by altering cellular metabolism and inducing oxidative/ER stress-mediated apoptosis and pyroptosis

The Tumor Suppressor Zinc Finger Protein 471 Suppresses Breast Cancer Growth and Metastasis Through Inhibiting AKT and Wnt/β-catenin Signaling

Lncrna Loc285194 Is A P53-Regulated Tumor Suppressor